Literature DB >> 34309407

Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants.

Krystian Kozek1, Yuko Wada1,2, Luca Sala3, Isabelle Denjoy4, Christian Egly1, Matthew J O'Neill1, Takeshi Aiba5, Wataru Shimizu6, Naomasa Makita5,7, Taisuke Ishikawa7, Lia Crotti3,8,9,10, Carla Spazzolini9, Maria-Christina Kotta, Federica Dagradi9, Silvia Castelletti9, Matteo Pedrazzini3, Massimiliano Gnecchi11,12, Antoine Leenhardt4,13, Joe-Elie Salem14,15, Seiko Ohno2,5, Yi Zuo16, Andrew M Glazer1, Jonathan D Mosley1,16,17, Dan M Roden1,16, Bjorn C Knollmann1, Jeffrey D Blume, Fabrice Extramiana4,13, Peter J Schwartz3,9, Minoru Horie2, Brett M Kroncke1.   

Abstract

BACKGROUND: The proliferation of genetic profiling has revealed many associations between genetic variations and disease. However, large-scale phenotyping efforts in largely healthy populations, coupled with DNA sequencing, suggest variants currently annotated as pathogenic are more common in healthy populations than previously thought. In addition, novel and rare variants are frequently observed in genes associated with disease both in healthy individuals and those under suspicion of disease. This raises the question of whether these variants can be useful predictors of disease. To answer this question, we assessed the degree to which the presence of a variant in the cardiac potassium channel gene KCNH2 was diagnostically predictive for the autosomal dominant long QT syndrome.
METHODS: We estimated the probability of a long QT diagnosis given the presence of each KCNH2 variant using Bayesian methods that incorporated variant features such as changes in variant function, protein structure, and in silico predictions. We call this estimate the posttest probability of disease. Our method was applied to over 4000 individuals heterozygous for 871 missense or in-frame insertion/deletion variants in KCNH2 and validated against a separate international cohort of 933 individuals heterozygous for 266 missense or in-frame insertion/deletion variants.
RESULTS: Our method was well-calibrated for the observed fraction of heterozygotes diagnosed with long QT syndrome. Heuristically, we found that the innate diagnostic information one learns about a variant from 3-dimensional variant location, in vitro functional data, and in silico predictors is equivalent to the diagnostic information one learns about that same variant by clinically phenotyping 10 heterozygotes. Most importantly, these data can be obtained in the absence of any clinical observations.
CONCLUSIONS: We show how variant-specific features can inform a prior probability of disease for rare variants even in the absence of clinically phenotyped heterozygotes.

Entities:  

Keywords:  genetic variation; heterozygotes; ion channel; long QT syndrome; phenotype

Mesh:

Substances:

Year:  2021        PMID: 34309407      PMCID: PMC8373797          DOI: 10.1161/CIRCGEN.120.003289

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN: 2574-8300


  50 in total

Review 1.  Beyond Mendel: an evolving view of human genetic disease transmission.

Authors:  Jose L Badano; Nicholas Katsanis
Journal:  Nat Rev Genet       Date:  2002-10       Impact factor: 53.242

2.  KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.

Authors:  Lia Crotti; Andrew L Lundquist; Roberto Insolia; Matteo Pedrazzini; Chiara Ferrandi; Gaetano M De Ferrari; Alessandro Vicentini; Ping Yang; Dan M Roden; Alfred L George; Peter J Schwartz
Journal:  Circulation       Date:  2005-08-22       Impact factor: 29.690

3.  High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KV11.1.

Authors:  Krystian A Kozek; Andrew M Glazer; Chai-Ann Ng; Daniel Blackwell; Christian L Egly; Loren R Vanags; Marcia Blair; Devyn Mitchell; Kenneth A Matreyek; Douglas M Fowler; Bjorn C Knollmann; Jamie I Vandenberg; Dan M Roden; Brett M Kroncke
Journal:  Heart Rhythm       Date:  2020-06-06       Impact factor: 6.343

4.  Long QT syndrome type 5-Lite: Defining the clinical phenotype associated with the potentially proarrhythmic p.Asp85Asn-KCNE1 common genetic variant.

Authors:  Conor M Lane; John R Giudicessi; Dan Ye; David J Tester; Ram K Rohatgi; J Martijn Bos; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2018-04-03       Impact factor: 6.343

5.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.

Authors:  Frederick E Dewey; Michael F Murray; John D Overton; Lukas Habegger; Joseph B Leader; Samantha N Fetterolf; Colm O'Dushlaine; Cristopher V Van Hout; Jeffrey Staples; Claudia Gonzaga-Jauregui; Raghu Metpally; Sarah A Pendergrass; Monica A Giovanni; H Lester Kirchner; Suganthi Balasubramanian; Noura S Abul-Husn; Dustin N Hartzel; Daniel R Lavage; Korey A Kost; Jonathan S Packer; Alexander E Lopez; John Penn; Semanti Mukherjee; Nehal Gosalia; Manoj Kanagaraj; Alexander H Li; Lyndon J Mitnaul; Lance J Adams; Thomas N Person; Kavita Praveen; Anthony Marcketta; Matthew S Lebo; Christina A Austin-Tse; Heather M Mason-Suares; Shannon Bruse; Scott Mellis; Robert Phillips; Neil Stahl; Andrew Murphy; Aris Economides; Kimberly A Skelding; Christopher D Still; James R Elmore; Ingrid B Borecki; George D Yancopoulos; F Daniel Davis; William A Faucett; Omri Gottesman; Marylyn D Ritchie; Alan R Shuldiner; Jeffrey G Reid; David H Ledbetter; Aris Baras; David J Carey
Journal:  Science       Date:  2016-12-23       Impact factor: 47.728

6.  REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.

Authors:  Nilah M Ioannidis; Joseph H Rothstein; Vikas Pejaver; Sumit Middha; Shannon K McDonnell; Saurabh Baheti; Anthony Musolf; Qing Li; Emily Holzinger; Danielle Karyadi; Lisa A Cannon-Albright; Craig C Teerlink; Janet L Stanford; William B Isaacs; Jianfeng Xu; Kathleen A Cooney; Ethan M Lange; Johanna Schleutker; John D Carpten; Isaac J Powell; Olivier Cussenot; Geraldine Cancel-Tassin; Graham G Giles; Robert J MacInnis; Christiane Maier; Chih-Lin Hsieh; Fredrik Wiklund; William J Catalona; William D Foulkes; Diptasri Mandal; Rosalind A Eeles; Zsofia Kote-Jarai; Carlos D Bustamante; Daniel J Schaid; Trevor Hastie; Elaine A Ostrander; Joan E Bailey-Wilson; Predrag Radivojac; Stephen N Thibodeau; Alice S Whittemore; Weiva Sieh
Journal:  Am J Hum Genet       Date:  2016-09-22       Impact factor: 11.025

7.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

8.  Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.

Authors:  Roddy Walsh; Kate L Thomson; James S Ware; Birgit H Funke; Jessica Woodley; Karen J McGuire; Francesco Mazzarotto; Edward Blair; Anneke Seller; Jenny C Taylor; Eric V Minikel; Daniel G MacArthur; Martin Farrall; Stuart A Cook; Hugh Watkins
Journal:  Genet Med       Date:  2016-08-17       Impact factor: 8.822

9.  Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.

Authors:  Sean V Tavtigian; Marc S Greenblatt; Steven M Harrison; Robert L Nussbaum; Snehit A Prabhu; Kenneth M Boucher; Leslie G Biesecker
Journal:  Genet Med       Date:  2018-01-04       Impact factor: 8.822

10.  Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome.

Authors:  Najim Lahrouchi; Rafik Tadros; Lia Crotti; Yuka Mizusawa; Pieter G Postema; Leander Beekman; Roddy Walsh; Kanae Hasegawa; Julien Barc; Marko Ernsting; Kari L Turkowski; Andrea Mazzanti; Britt M Beckmann; Keiko Shimamoto; Ulla-Britt Diamant; Yanushi D Wijeyeratne; Yu Kucho; Tomas Robyns; Taisuke Ishikawa; Elena Arbelo; Michael Christiansen; Annika Winbo; Reza Jabbari; Steven A Lubitz; Johannes Steinfurt; Boris Rudic; Bart Loeys; M Ben Shoemaker; Peter E Weeke; Ryan Pfeiffer; Brianna Davies; Antoine Andorin; Nynke Hofman; Federica Dagradi; Matteo Pedrazzini; David J Tester; J Martijn Bos; Georgia Sarquella-Brugada; Óscar Campuzano; Pyotr G Platonov; Birgit Stallmeyer; Sven Zumhagen; Eline A Nannenberg; Jan H Veldink; Leonard H van den Berg; Ammar Al-Chalabi; Christopher E Shaw; Pamela J Shaw; Karen E Morrison; Peter M Andersen; Martina Müller-Nurasyid; Daniele Cusi; Cristina Barlassina; Pilar Galan; Mark Lathrop; Markus Munter; Thomas Werge; Marta Ribasés; Tin Aung; Chiea C Khor; Mineo Ozaki; Peter Lichtner; Thomas Meitinger; J Peter van Tintelen; Yvonne Hoedemaekers; Isabelle Denjoy; Antoine Leenhardt; Carlo Napolitano; Wataru Shimizu; Jean-Jacques Schott; Jean-Baptiste Gourraud; Takeru Makiyama; Seiko Ohno; Hideki Itoh; Andrew D Krahn; Charles Antzelevitch; Dan M Roden; Johan Saenen; Martin Borggrefe; Katja E Odening; Patrick T Ellinor; Jacob Tfelt-Hansen; Jonathan R Skinner; Maarten P van den Berg; Morten Salling Olesen; Josep Brugada; Ramón Brugada; Naomasa Makita; Jeroen Breckpot; Masao Yoshinaga; Elijah R Behr; Annika Rydberg; Takeshi Aiba; Stefan Kääb; Silvia G Priori; Pascale Guicheney; Hanno L Tan; Christopher Newton-Cheh; Michael J Ackerman; Peter J Schwartz; Eric Schulze-Bahr; Vincent Probst; Minoru Horie; Arthur A Wilde; Michael W T Tanck; Connie R Bezzina
Journal:  Circulation       Date:  2020-05-20       Impact factor: 39.918

View more
  2 in total

1.  A massively parallel assay accurately discriminates between functionally normal and abnormal variants in a hotspot domain of KCNH2.

Authors:  Chai-Ann Ng; Rizwan Ullah; Jessica Farr; Adam P Hill; Krystian A Kozek; Loren R Vanags; Devyn W Mitchell; Brett M Kroncke; Jamie I Vandenberg
Journal:  Am J Hum Genet       Date:  2022-06-09       Impact factor: 11.043

2.  Towards generalizable predictions for G protein-coupled receptor variant expression.

Authors:  Charles P Kuntz; Hope Woods; Andrew G McKee; Nathan B Zelt; Jeffrey L Mendenhall; Jens Meiler; Jonathan P Schlebach
Journal:  Biophys J       Date:  2022-06-17       Impact factor: 3.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.